Creyon Bio, Cajal Neuroscience to Jointly Target Neurodegenerative Diseases
By Daniella Parra Creyon Bio, Inc. and Cajal Neuroscience have teamed up to develop...
By Daniella Parra Creyon Bio, Inc. and Cajal Neuroscience have teamed up to develop...
By Karen Roman Agendia, Inc.’s BluePrint was recently included in the latest version of German...
By Daniella Parra Gameto, a female-led biotechnology firm, said it received tentative FDA approval to...
By Karen Roman Orthobond Corp. said the Food and Drug Administration approved its request to...
By Karen Roman Acumen Pharmaceuticals, Inc. (Nasdaq: ABOS), a clinical-stage biopharmaceutical company, announced it signed...
By Daniella Parra Gameto, a biotech firm focused on women’s healthcare, shared a study examining...
By Karen Roman REGENXBIO Inc. (Nasdaq: RGNX), a clinical-stage biotechnology company, said its subretinal treatment...
By Karen Roman Agendia, Inc., a biotechnology company that provides molecular diagnostics and cancer treatment,...
By Daniella Parra Conduit Pharmaceuticals Inc. (Nasdaq: CDT) announced the appointment of Dr. Joanne Holland...
By Karen Roman Conduit Pharmaceuticals Inc. (Nasdaq: CDT), a clinical-stage life science company, reported it...